Polycystic kidney disease.

Pamela J. Fall, L. Michael Prisant

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Polycystic kidney disease, an inherited systemic disorder, is characterized by the development of multiple cysts in the kidneys and other organs. Patients can present at any age, but more often come to clinical attention (unless there is a family history) after age 30. Patients who are diagnosed before age 30 have a worse renal survival. Although palpation of the abdomen occasionally provides a clue to the presence of polycystic kidney disease, radiographic procedures most often suggest the diagnosis. Mutations in the PKD1 or PKD2 genes give rise to cyst formation. Flank pain, hematuria, polyuria, nephrolithiasis, urinary tract infections, and hypertension may be part of the syndrome of polycystic kidney disease. It is the fourth most common cause of end-stage renal disease. Blood pressure treatment goals are less than 130/80 mm Hg. Treatment should include the use of angiotensin-converting enzyme inhibitors.

Original languageEnglish (US)
JournalJournal of clinical hypertension (Greenwich, Conn.)
Volume7
Issue number10
DOIs
StatePublished - Jan 1 2005

Fingerprint

Polycystic Kidney Diseases
Cysts
Kidney
Flank Pain
Polyuria
Nephrolithiasis
Palpation
Hematuria
Angiotensin-Converting Enzyme Inhibitors
Urinary Tract Infections
Abdomen
Chronic Kidney Failure
Blood Pressure
Hypertension
Mutation
Therapeutics
Genes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Cardiology and Cardiovascular Medicine

Cite this

Polycystic kidney disease. / Fall, Pamela J.; Prisant, L. Michael.

In: Journal of clinical hypertension (Greenwich, Conn.), Vol. 7, No. 10, 01.01.2005.

Research output: Contribution to journalArticle

Fall, Pamela J. ; Prisant, L. Michael. / Polycystic kidney disease. In: Journal of clinical hypertension (Greenwich, Conn.). 2005 ; Vol. 7, No. 10.
@article{7ad4e3b8abd74157baceccc706971d90,
title = "Polycystic kidney disease.",
abstract = "Polycystic kidney disease, an inherited systemic disorder, is characterized by the development of multiple cysts in the kidneys and other organs. Patients can present at any age, but more often come to clinical attention (unless there is a family history) after age 30. Patients who are diagnosed before age 30 have a worse renal survival. Although palpation of the abdomen occasionally provides a clue to the presence of polycystic kidney disease, radiographic procedures most often suggest the diagnosis. Mutations in the PKD1 or PKD2 genes give rise to cyst formation. Flank pain, hematuria, polyuria, nephrolithiasis, urinary tract infections, and hypertension may be part of the syndrome of polycystic kidney disease. It is the fourth most common cause of end-stage renal disease. Blood pressure treatment goals are less than 130/80 mm Hg. Treatment should include the use of angiotensin-converting enzyme inhibitors.",
author = "Fall, {Pamela J.} and Prisant, {L. Michael}",
year = "2005",
month = "1",
day = "1",
doi = "10.1111/j.1524-6175.2005.04137.x",
language = "English (US)",
volume = "7",
journal = "Journal of the CardioMetabolic Syndrome",
issn = "1524-6175",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - Polycystic kidney disease.

AU - Fall, Pamela J.

AU - Prisant, L. Michael

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Polycystic kidney disease, an inherited systemic disorder, is characterized by the development of multiple cysts in the kidneys and other organs. Patients can present at any age, but more often come to clinical attention (unless there is a family history) after age 30. Patients who are diagnosed before age 30 have a worse renal survival. Although palpation of the abdomen occasionally provides a clue to the presence of polycystic kidney disease, radiographic procedures most often suggest the diagnosis. Mutations in the PKD1 or PKD2 genes give rise to cyst formation. Flank pain, hematuria, polyuria, nephrolithiasis, urinary tract infections, and hypertension may be part of the syndrome of polycystic kidney disease. It is the fourth most common cause of end-stage renal disease. Blood pressure treatment goals are less than 130/80 mm Hg. Treatment should include the use of angiotensin-converting enzyme inhibitors.

AB - Polycystic kidney disease, an inherited systemic disorder, is characterized by the development of multiple cysts in the kidneys and other organs. Patients can present at any age, but more often come to clinical attention (unless there is a family history) after age 30. Patients who are diagnosed before age 30 have a worse renal survival. Although palpation of the abdomen occasionally provides a clue to the presence of polycystic kidney disease, radiographic procedures most often suggest the diagnosis. Mutations in the PKD1 or PKD2 genes give rise to cyst formation. Flank pain, hematuria, polyuria, nephrolithiasis, urinary tract infections, and hypertension may be part of the syndrome of polycystic kidney disease. It is the fourth most common cause of end-stage renal disease. Blood pressure treatment goals are less than 130/80 mm Hg. Treatment should include the use of angiotensin-converting enzyme inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=33645080484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645080484&partnerID=8YFLogxK

U2 - 10.1111/j.1524-6175.2005.04137.x

DO - 10.1111/j.1524-6175.2005.04137.x

M3 - Article

C2 - 16227765

AN - SCOPUS:33645080484

VL - 7

JO - Journal of the CardioMetabolic Syndrome

JF - Journal of the CardioMetabolic Syndrome

SN - 1524-6175

IS - 10

ER -